FG-3019

fresolimumab · FibroGen, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FG-3019, covering 2007-12-12 to 2023-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 1, Phase 2]

See pricing